The PLACORHEN study: a double-blind, placebo-controlled, randomized radionuclide study with (186)Re-etidronate in hormone-resistant prostate cancer patients witgh painful bone metastases. Placebo Controlled Rhenium sTUDY.

S. Han; J.M.H. de Klerk; S. Tan; A.D. van het Schip; B.H. Derksen; A. van Dijk; C.L.J.J. Kruitwagen; G.H. Blijham; P.P. van Rijk; B.A. Zonnenberg

The PLACORHEN study: a double-blind, placebo-controlled, randomized radionuclide study with (186)Re-etidronate in hormone-resistant prostate cancer patients witgh painful bone metastases. Placebo Controlled Rhenium sTUDY.

Translated title of the contribution: The PLACORHEN study: a double-blind, placebo-controlled, randomized radionuclide study with (186)Re-etidronate in hormone-resistant prostate cancer patients witgh painful bone metastases. Placebo Controlled Rhenium sTUDY.

S. Han
, J.M.H. de Klerk
, S. Tan
, A.D. van het Schip
, B.H. Derksen
, A. van Dijk
, C.L.J.J. Kruitwagen
, G.H. Blijham
, P.P. van Rijk
, B.A. Zonnenberg

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	The PLACORHEN study: a double-blind, placebo-controlled, randomized radionuclide study with (186)Re-etidronate in hormone-resistant prostate cancer patients witgh painful bone metastases. Placebo Controlled Rhenium sTUDY.
Original language	Undefined/Unknown
Pages (from-to)	1150-1156
Number of pages	7
Journal	Journal of Nuclear Medicine
Volume	43
Publication status	Published - 2002

Cite this

Han, S., de Klerk, J. M. H., Tan, S., van het Schip, A. D., Derksen, B. H., van Dijk, A., Kruitwagen, C. L. J. J., Blijham, G. H., van Rijk, P. P., & Zonnenberg, B. A. (2002). The PLACORHEN study: a double-blind, placebo-controlled, randomized radionuclide study with (186)Re-etidronate in hormone-resistant prostate cancer patients witgh painful bone metastases. Placebo Controlled Rhenium sTUDY. Journal of Nuclear Medicine, 43, 1150-1156.

@article{05649d1aea864f5992c0b626219fab2b,

title = "The PLACORHEN study: a double-blind, placebo-controlled, randomized radionuclide study with (186)Re-etidronate in hormone-resistant prostate cancer patients witgh painful bone metastases. Placebo Controlled Rhenium sTUDY.",

author = "S. Han and \{de Klerk\}, J.M.H. and S. Tan and \{van het Schip\}, A.D. and B.H. Derksen and \{van Dijk\}, A. and C.L.J.J. Kruitwagen and G.H. Blijham and \{van Rijk\}, P.P. and B.A. Zonnenberg",

year = "2002",

language = "Undefined/Unknown",

volume = "43",

pages = "1150--1156",

journal = "Journal of Nuclear Medicine",

issn = "0161-5505",

publisher = "Society of Nuclear Medicine Inc.",

}

Han, S, de Klerk, JMH, Tan, S, van het Schip, AD, Derksen, BH, van Dijk, A, Kruitwagen, CLJJ, Blijham, GH, van Rijk, PP & Zonnenberg, BA 2002, 'The PLACORHEN study: a double-blind, placebo-controlled, randomized radionuclide study with (186)Re-etidronate in hormone-resistant prostate cancer patients witgh painful bone metastases. Placebo Controlled Rhenium sTUDY.', Journal of Nuclear Medicine, vol. 43, pp. 1150-1156.

The PLACORHEN study: a double-blind, placebo-controlled, randomized radionuclide study with (186)Re-etidronate in hormone-resistant prostate cancer patients witgh painful bone metastases. Placebo Controlled Rhenium sTUDY. / Han, S.; de Klerk, J.M.H.; Tan, S. et al.
In: Journal of Nuclear Medicine, Vol. 43, 2002, p. 1150-1156.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The PLACORHEN study: a double-blind, placebo-controlled, randomized radionuclide study with (186)Re-etidronate in hormone-resistant prostate cancer patients witgh painful bone metastases. Placebo Controlled Rhenium sTUDY.

AU - Han, S.

AU - de Klerk, J.M.H.

AU - Tan, S.

AU - van het Schip, A.D.

AU - Derksen, B.H.

AU - van Dijk, A.

AU - Kruitwagen, C.L.J.J.

AU - Blijham, G.H.

AU - van Rijk, P.P.

AU - Zonnenberg, B.A.

PY - 2002

Y1 - 2002

M3 - Article

SN - 0161-5505

VL - 43

SP - 1150

EP - 1156

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

ER -